Literature DB >> 9741349

Biological activities of C3 beta c, a novel neutrophil chemoattractant derived from the beta-chain of rat complement C3.

H Nakagawa1, Y Sunada, Y Ando.   

Abstract

Biological activities of C3 beta c, which is a C-terminal fragment of the beta-chain of rat complement C3, have been studied by in vivo and in vitro experiments. C3 beta c was purified as a novel neutrophil chemoattractant from the exudate of the chronic phase of rat carrageenin-induced inflammation. The purified C3 beta c induced neutrophil chemotaxis in vivo when C3 beta c was injected into the preformed air-pouch on the back of rats. C3 beta c transiently increased the intracellular free Ca2+ concentration of neutrophils and enhanced the adhesion of neutrophils to fibrinogen in vitro, suggesting that C3 beta c has the ability to express an adhesion molecule of rat neutrophils. In addition, C3 beta c at low concentrations (10(-10)-10(-11) M) stimulated rat macrophages to produce cytokine-induced neutrophil chemoattractant-2, a member of the interleukin-8 family. Furthermore, C3 beta c enhanced vascular permeability in vivo, which is suppressed by cyproheptadine, suggesting that C3 beta c may have the characteristics of an anaphylatoxin. Our results suggest that C3 beta c contributes to oedema formation and neutrophil accumulation at inflammatory sites in rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741349      PMCID: PMC1364213          DOI: 10.1046/j.1365-2567.1998.00506.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

Review 1.  Role of complement in inflammation and bacterial killing.

Authors:  P J Späth
Journal:  Curr Stud Hematol Blood Transfus       Date:  1992

2.  A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8.

Authors:  S Nourshargh; J A Perkins; H J Showell; K Matsushima; T J Williams; P D Collins
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

Review 3.  The role of complement in inflammation and phagocytosis.

Authors:  M M Frank; L F Fries
Journal:  Immunol Today       Date:  1991-09

Review 4.  Structure and function of C3a anaphylatoxin.

Authors:  T E Hugli
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

5.  Characterization of a receptor for C5a anaphylatoxin on human eosinophils.

Authors:  N P Gerard; M K Hodges; J M Drazen; P F Weller; C Gerard
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

Review 6.  Anaphylatoxins: C3a and C5a.

Authors:  T E Hugli; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

7.  The effect of locally injected anti-inflammatory drugs on the carrageenin granuloma in rats.

Authors:  M Fukuhara; S Tsurufuji
Journal:  Biochem Pharmacol       Date:  1969-02       Impact factor: 5.858

8.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

9.  Differential changes in the concentrations of cytokine-induced neutrophil chemoattractant (CINC)-1 and CINC-2 in exudate during rat lipopolysaccharide-induced inflammation.

Authors:  F Shibata; H Kato; K Konishi; A Okumora; H Ochiai; K Nakajima; M Al-Mokdad; H Nakagawa
Journal:  Cytokine       Date:  1996-03       Impact factor: 3.861

10.  Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen.

Authors:  S D Wright; J I Weitz; A J Huang; S M Levin; S C Silverstein; J D Loike
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

View more
  1 in total

1.  Abundant proteins in platelet-rich fibrin and their potential contribution to wound healing: An explorative proteomics study and review of the literature.

Authors:  Emre Yaprak; Murat Kasap; Gurler Akpinar; Eylul Ece Islek; Alper Sinanoglu
Journal:  J Dent Sci       Date:  2018-09-03       Impact factor: 2.080

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.